Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Trapani

Showing results (321-330 of 351) with videos related to

Pageof 36
Sort By:
Cell Reports|November 14, 2024
Tissue-colonizing disseminated tumor cells secrete prostaglandin E2 to promote NK cell dysfunction and evade anti-metastatic immunityAnna-Marie Pedde, Hyunu Kim, Sainitin Donakonda, et al.
Molecular Cell|August 26, 2025
A CDK11-dependent RNA polymerase II pause-checkpoint precedes CDK9-mediated transition to transcriptional elongationJennifer R Devlin, Ben Martin, Nenad Bartonicek, et al.
Science Immunology|May 20, 2018
Tumor immune evasion arises through loss of TNF sensitivityConor J Kearney, Stephin J Vervoort, Simon J Hogg, et al.
Nature Communications|September 21, 2017
Agonist immunotherapy restores T cell function following MEK inhibition improving efficacy in breast cancerSathana Dushyanthen, Zhi Ling Teo, Franco Caramia, et al.
The Journal of Clinical Investigation|February 7, 2017
Targeting the adenosine 2A receptor enhances chimeric antigen receptor T cell efficacyPaul A Beavis, Melissa A Henderson, Lauren Giuffrida, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 27, 2009
The Lewis-Y carbohydrate antigen is expressed by many human tumors and can serve as a target for genetically redirected T cells despite the presence of soluble antigen in serumJennifer A Westwood, William K Murray, Melanie Trivett, et al.
Nature|November 2, 2010
The structural basis for membrane binding and pore formation by lymphocyte perforinRuby H P Law, Natalya Lukoyanova, Ilia Voskoboinik, et al.
Journal of Hepatology|May 30, 2024
CRISPR-Cas13b-mediated suppression of HBV replication and protein expressionLaura C McCoullough, Mohamed Fareh, Wenxin Hu, et al.
Haematologica|June 30, 2022
The efficacy of combination treatment with elotuzumab and lenalidomide is dependent on crosstalk between natural killer cells, monocytes and myeloma cellsKelden Richardson, Simon P Keam, Joe Jiang Zhu, et al.
The Biochemical Journal|September 28, 2013
Defining the interaction of perforin with calcium and the phospholipid membraneDaouda A K Traore, Amelia J Brennan, Ruby H P Law, et al.
Pageof 36

Showing results (321-330 of 351) with videos related to

Sort By:
Pageof 36
Cell Reports|November 14, 2024
Tissue-colonizing disseminated tumor cells secrete prostaglandin E2 to promote NK cell dysfunction and evade anti-metastatic immunityAnna-Marie Pedde, Hyunu Kim, Sainitin Donakonda, et al.
Molecular Cell|August 26, 2025
A CDK11-dependent RNA polymerase II pause-checkpoint precedes CDK9-mediated transition to transcriptional elongationJennifer R Devlin, Ben Martin, Nenad Bartonicek, et al.
Science Immunology|May 20, 2018
Tumor immune evasion arises through loss of TNF sensitivityConor J Kearney, Stephin J Vervoort, Simon J Hogg, et al.
Nature Communications|September 21, 2017
Agonist immunotherapy restores T cell function following MEK inhibition improving efficacy in breast cancerSathana Dushyanthen, Zhi Ling Teo, Franco Caramia, et al.
The Journal of Clinical Investigation|February 7, 2017
Targeting the adenosine 2A receptor enhances chimeric antigen receptor T cell efficacyPaul A Beavis, Melissa A Henderson, Lauren Giuffrida, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 27, 2009
The Lewis-Y carbohydrate antigen is expressed by many human tumors and can serve as a target for genetically redirected T cells despite the presence of soluble antigen in serumJennifer A Westwood, William K Murray, Melanie Trivett, et al.
Nature|November 2, 2010
The structural basis for membrane binding and pore formation by lymphocyte perforinRuby H P Law, Natalya Lukoyanova, Ilia Voskoboinik, et al.
Journal of Hepatology|May 30, 2024
CRISPR-Cas13b-mediated suppression of HBV replication and protein expressionLaura C McCoullough, Mohamed Fareh, Wenxin Hu, et al.
Haematologica|June 30, 2022
The efficacy of combination treatment with elotuzumab and lenalidomide is dependent on crosstalk between natural killer cells, monocytes and myeloma cellsKelden Richardson, Simon P Keam, Joe Jiang Zhu, et al.
The Biochemical Journal|September 28, 2013
Defining the interaction of perforin with calcium and the phospholipid membraneDaouda A K Traore, Amelia J Brennan, Ruby H P Law, et al.
Pageof 36